Emily Goodman
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Resident Physician
Also affiliated: Emory University (2013–2014); University of Arkansas Medical Center (2026); Drake University (2025)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Emily Goodman's research has investigated various aspects of health and medical science. Her work includes studies on the efficacy of the anti-CELA1 antibody KF4 in preventing emphysema, with some publications exploring its effects in murine models and comparing it to purified α1-Antitrypsin. Goodman has also contributed to research on opioid prescribing behaviors among surgical intensive care unit attending physicians and the inpatient screening of parental adversity and strengths.
Further research interests include qualitative studies on cultivating social relationships and disrupting social isolation in low-income neighborhoods. Additionally, Goodman has conducted a scoping review on hearing outcomes following ventriculoperitoneal shunt placement and co-authored a systematic review and meta-analysis on the management and outcomes of recurrent ranulas. Her scholarship metrics include an h-index of 6 with 112 total citations across 18 publications.
Metrics
- h-index: 6
- Publications: 18
- Citations: 114
Selected Publications
-
Hearing Outcomes Following Ventriculoperitoneal Shunt Placement: A Scoping Review (2026)
-
Systematic Review and Meta‐Analysis of the Management and Outcomes of Recurrent Ranulas (2026)
-
KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency (2024)
-
Exploring the Prevalence of Psychiatric Disorders in Otosclerosis Patients: A Systematic Review (2024)
-
KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency (2024)
-
Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling (2024)
-
Ectopic lateral neck thymus: A case report and review of management (2023)
-
Opioid Prescribing Behaviors Among Surgical Intensive Care Unit Attending Physicians (2022)
-
Anti-CELA1 KF4 Antibody Prevents Emphysema by Inhibiting Stretch-Mediated Remodeling (2020)
Collaboration Network
Top Collaborators
- Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
- KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
- Exploring the Prevalence of Psychiatric Disorders in Otosclerosis Patients: A Systematic Review
- Hearing Outcomes Following Ventriculoperitoneal Shunt Placement: A Scoping Review
- Systematic Review and Meta‐Analysis of the Management and Outcomes of Recurrent Ranulas
- Hearing Outcomes Following Ventriculoperitoneal Shunt Placement: A Scoping Review
- Systematic Review and Meta‐Analysis of the Management and Outcomes of Recurrent Ranulas
- Hearing Outcomes Following Ventriculoperitoneal Shunt Placement: A Scoping Review
- Opioid Prescribing Behaviors Among Surgical Intensive Care Unit Attending Physicians
- Opioid Prescribing Behaviors Among Surgical Intensive Care Unit Attending Physicians
- Opioid Prescribing Behaviors Among Surgical Intensive Care Unit Attending Physicians
Similar Researchers
Based on overlapping research topics